These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23734347)

  • 1. Blood biomarker measurement as disease target: the case for generic treatment of high natriuretic peptide levels without a diagnosis of heart failure.
    Clark AL
    J R Coll Physicians Edinb; 2013; 43(2):99-100. PubMed ID: 23734347
    [No Abstract]   [Full Text] [Related]  

  • 2. Natriuretic peptides in the diagnosis and management of acute heart failure.
    Mohammed AA; Januzzi JL
    Heart Fail Clin; 2009 Oct; 5(4):489-500. PubMed ID: 19631174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natriuretic peptides as a prognostic marker and therapeutic target in heart failure.
    Wright GA; Struthers AD
    Heart; 2006 Feb; 92(2):149-51. PubMed ID: 16216866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Natriuretic peptides--new diagnostic markers in heart disease].
    Angermann CE; Ertl G
    Herz; 2004 Sep; 29(6):609-17. PubMed ID: 15912436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can we IMPROVE-CHF management by measuring natriuretic peptides?
    Greenberg B
    Circulation; 2007 Jun; 115(24):3045-7. PubMed ID: 17576881
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical utility of natriuretic peptdies in dyspnea].
    Müller C
    Ther Umsch; 2009 Sep; 66(9):649-52. PubMed ID: 19725009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reducing variation: heart: Modelling helps to prove blood test value.
    Health Serv J; 2011 Sep; Suppl():18. PubMed ID: 22053508
    [No Abstract]   [Full Text] [Related]  

  • 8. [Biomarkers in heart failure: are they clinically useful?].
    Kempf T; Wollert KC
    Dtsch Med Wochenschr; 2009 Apr; 134(15):740-6. PubMed ID: 19340752
    [No Abstract]   [Full Text] [Related]  

  • 9. Natriuretic peptide testing for heart failure therapy guidance in the inpatient and outpatient setting.
    Green SM; Green JA; Januzzi JL
    Am J Ther; 2009; 16(2):171-7. PubMed ID: 19300043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: new challenges and perspectives.
    Clerico A; Passino C; Franzini M; Emdin M
    Future Cardiol; 2016 Sep; 12(5):573-84. PubMed ID: 27459871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical relevance of non-cardiac determinants of natriuretic peptide levels.
    Passino C; Poletti R; Fontana M; Vergaro G; Prontera C; Gabutti A; Giannoni A; Emdin M; Clerico A
    Clin Chem Lab Med; 2008; 46(11):1515-23. PubMed ID: 19012517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natriuretic peptide measurements as part of the diagnostic work-up in pleural effusions: an emerging concept?
    Mueller T; Haltmayer M
    Eur Respir J; 2006 Jul; 28(1):7-9. PubMed ID: 16816345
    [No Abstract]   [Full Text] [Related]  

  • 13. B-type natriuretic peptide: time to incorporate natriuretic peptides in our practice.
    Daniels LB; Maisel A
    J Cardiovasc Med (Hagerstown); 2006 Jun; 7(6):414-5. PubMed ID: 16721203
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of natriuretic peptides as biomarkers for guiding the management of chronic heart failure.
    Motiwala SR; Januzzi JL
    Clin Pharmacol Ther; 2013 Jan; 93(1):57-67. PubMed ID: 23187878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Tailored drug therapy in heart failure--a future vision. Biological markers can support individually directed treatment].
    Dahlström U
    Lakartidningen; 2009 Oct 14-20; 106(42):2674-5. PubMed ID: 19967945
    [No Abstract]   [Full Text] [Related]  

  • 16. [Role of biomarkers for risk stratification in the tailored follow-up of heart failure patients].
    Aspromonte N; Di Tano G; Latini R; Masson S; Valle R; Emdin M
    G Ital Cardiol (Rome); 2010 May; 11(5 Suppl 2):17S-23S. PubMed ID: 20873464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amino terminal B-type natriuretic peptide, renal function, and prognosis in acute heart failure: a hospital cohort study.
    Pimenta JM; Almeida R; Araújo JP; Azevedo A; Friões F; Rocha-Gonçalves F; Ferreira A; Bettencourt P
    J Card Fail; 2007 May; 13(4):275-80. PubMed ID: 17517347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natriuretic peptides in heart failure: empathizing with the sobbing heart..
    Narula J; Young JB
    Heart Fail Clin; 2006 Jul; 2(3):xi-xiii. PubMed ID: 17386893
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma natriuretic peptide levels and the risk of cardiovascular events and death.
    Wang TJ; Larson MG; Levy D; Benjamin EJ; Leip EP; Omland T; Wolf PA; Vasan RS
    N Engl J Med; 2004 Feb; 350(7):655-63. PubMed ID: 14960742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does measuring natriuretic peptides have a role in patients with chronic kidney disease?
    Hajjar V; Schreiber MJ
    Cleve Clin J Med; 2009 Aug; 76(8):476-8. PubMed ID: 19652041
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.